Pacific Edge Ltd
NZX:PEB

Watchlist Manager
Pacific Edge Ltd Logo
Pacific Edge Ltd
NZX:PEB
Watchlist
Price: 0.098 NZD 2.08% Market Closed
Market Cap: 79.6m NZD

P/S
Price to Sales

3.7
Current
5.1
Median
7
Industry
Lower than median
Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
3.7
=
Market Cap
79.6m NZD
/
Revenue
21.8m NZD
Revenue Growth P/S to Growth
NZ
Pacific Edge Ltd
NZX:PEB
Average P/S: 3 165 439.8
3.7
-9%
N/A
FR
Pharnext SCA
OTC:PNEXF
34 817 737.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6
7%
0.9
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.5
3%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.7
10%
1.2
US
E
Epizyme Inc
F:EPE
2 023.4
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.5
6%
0.7
US
S
Seagen Inc
F:SGT
19.5
30%
0.6
NL
argenx SE
XBRU:ARGX
17.5
39%
0.4

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
3.9
2-Years Forward
P/S
6.1
3-Years Forward
P/S
4.4